Pharmaniaga touting stability to potential investors

by -
1513

Pharmaniaga touting stability to potential investorsExecutives at Malaysian pharmaceutical company Pharmaniaga say that the company is set to make up 10% of its majority stakeholder’s business in 2011, and 15% of business within the next five years.  Boustead Group owns approximately 97% of the company, but is looking to reduce its contribution to about 75% to satisfy regulators.

Pharmaniaga has standing orders of about RM800 million, with about 60% of its business coming from the public sector.  The company also plans to spend about RM40 million in capital expenditures this year, including beginning the process of halal-certification at its manufacturing plants.  Profits in 2009 were about RM81 million, but dropped to RM45 million in 2010.

 

 



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

Executives at Malaysian pharmaceutical company Pharmaniaga say that the company is set to make up 10% of its majority stakeholder’s business in 2011, and 15% of business within the next five years.  Boustead Group owns approximately 97% of the company, but is looking to reduce its contribution to about 75% to satisfy regulators. Pharmaniaga has standing orders of about RM800 million, with about 60% of its business coming from the public sector.  The company also plans to spend about RM40 million in capital expenditures this year, including beginning the process of halal-certification at its manufacturing plants.  Profits in 2009 were...

Pharmaniaga touting stability to potential investorsExecutives at Malaysian pharmaceutical company Pharmaniaga say that the company is set to make up 10% of its majority stakeholder’s business in 2011, and 15% of business within the next five years.  Boustead Group owns approximately 97% of the company, but is looking to reduce its contribution to about 75% to satisfy regulators.

Pharmaniaga has standing orders of about RM800 million, with about 60% of its business coming from the public sector.  The company also plans to spend about RM40 million in capital expenditures this year, including beginning the process of halal-certification at its manufacturing plants.  Profits in 2009 were about RM81 million, but dropped to RM45 million in 2010.

 

 



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

NO COMMENTS

Leave a Reply